FLI and FIB-4 in diagnosing metabolic dysfunction-associated steatotic liver disease in primary care: High prevalence and risk of significant disease
There is a high prevalence of MASLD in PHC, with a significant risk of liver fibrosis. These findings reinforce we need to develop public policies to defeat MASLD epidemics.
Authors
- Patrícia Gabriela Riedel
- Marcelo Rodrigues Gonçalves (ORCID: https://orcid.org/0000-0001-8516-8547)
- Larisse Longo (ORCID: https://orcid.org/0000-0002-4453-7227)
- Vivian Cristine Luft (ORCID: https://orcid.org/0000-0003-2371-9264)
- Márcia da Silva Vargas
- Mário Reis Álvares‐da‐Silva (ORCID: https://orcid.org/0000-0002-5001-246X)
- Dvora Joveleviths (ORCID: https://orcid.org/0000-0002-0741-0235)
- Gabriella Jonko
- Soheyla Mohd Souza Rabie
Institutions
- Universidade Federal do Rio Grande do Sul (BR)
- Hospital de Clínicas de Porto Alegre (BR)
Publication Details
- Journal
- Annals of Hepatology
- Published
- 2024-10-10
- DOI
- https://doi.org/10.1016/j.aohep.2024.101584
- Citations
- 2
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.77
Funders
- Hospital de Clínicas de Porto Alegre